Prospeo
Hero Section BackgroundHero Section Background
X-tosis

X-tosis Email Formats

Biotechnology Research1-10 Employees

X-tosis Email Formats

X-tosis uses 2 email formats. The most common is {first initial} (e.g., j@x-tosis.com), used 60% of the time.

FormatExamplePercentage
{first initial}
j@x-tosis.com
60%
{first name}
john@x-tosis.com
40%

Key Contact at X-tosis

Flag of US

Erin Henderson

Co-Founder and Chief Executive Officer

Company overview

HeadquartersXX
NAICS541714
Founded2024
Employees1-10

About X-tosis

At X-Tosis, we are pioneering the future of neurodegenerative disease treatment by targeting one of the most fundamental drivers of cellular decline: mitochondrial dysfunction. Our innovative compound, XTS, works by inhibiting VDAC1 oligomerization—an essential mechanism in the cascade of cell death, inflammation, and neurological damage seen across multiple neurodegenerative conditions. By restoring mitochondrial integrity and protecting cells from early dysfunction, we aim not to manage symptoms but to change the trajectory of these diseases entirely. Our mission is bold and clear: to stop neurodegeneration at its source.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

X-tosis has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

X-tosis has never raised funding before.

Frequently asked questions

X-tosis is located in XX.
X-tosis was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.
X-tosis has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

4.8

40,000 users

top 50
high performer
most used
tier 1 accuracy

Build leads list with verified emails & mobiles